H
Hyuk-Soo Seo
Researcher at Harvard University
Publications - 70
Citations - 2440
Hyuk-Soo Seo is an academic researcher from Harvard University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 20, co-authored 52 publications receiving 1676 citations. Previous affiliations of Hyuk-Soo Seo include Howard Hughes Medical Institute & University of Pennsylvania.
Papers
More filters
Journal ArticleDOI
Transcription control by the ENL YEATS domain in acute leukaemia
Michael A. Erb,Thomas G. Scott,Bin E. Li,Huafeng Xie,Huafeng Xie,Joshiawa Paulk,Hyuk-Soo Seo,Amanda Souza,Justin M. Roberts,Shiva Dastjerdi,Dennis L. Buckley,Neville E. Sanjana,Ophir Shalem,Ophir Shalem,Behnam Nabet,Rhamy Zeid,Nana K. Offei-Addo,Sirano Dhe-Paganon,Feng Zhang,Feng Zhang,Stuart H. Orkin,Georg E. Winter,James E. Bradner,James E. Bradner +23 more
TL;DR: This work identifies ENL as an unrecognized gene that is specifically required for proliferation in vitro and in vivo and suggests a mechanistic rationale for disrupting the YEATS domain in disease.
Journal ArticleDOI
Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands
David Remillard,Dennis L. Buckley,Joshiawa Paulk,Gerard L. Brien,Matthew Sonnett,Matthew Sonnett,Hyuk-Soo Seo,Shiva Dastjerdi,Martin Wühr,Sirano Dhe-Paganon,Scott A. Armstrong,James E. Bradner +11 more
TL;DR: The first BRD9-directed chemical degraders are created, through iterative design and testing of heterobifunctional ligands that bridge theBRD9 bromodomain and the cereblon E3 ubiquitin ligase complex, and reveal the tractability of non-BET bromidomain containing proteins to chemical degradation.
Journal ArticleDOI
Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands.
Lara Gechijian,Dennis L. Buckley,Matthew A. Lawlor,Jaime M. Reyes,Joshiawa Paulk,Christopher J. Ott,Georg E. Winter,Michael A. Erb,Thomas G. Scott,Mousheng Xu,Hyuk-Soo Seo,Sirano Dhe-Paganon,Nicholas Kwiatkowski,Jennifer A. Perry,Jun Qi,Nathanael S. Gray,James E. Bradner,James E. Bradner +17 more
TL;DR: In this paper, the multidomain, bromodomain-containing transcriptional regulator TRIM24 was used as a chemical probe of an emerging cancer dependency, and established a path forward for numerous selective yet ineffectual ligands for proteins of therapeutic interest.
Journal ArticleDOI
A Fence-like Coat for the Nuclear Pore Membrane
Erik W. Debler,Yingli Ma,Hyuk-Soo Seo,Kuo-Chiang Hsia,Thomas R. Noriega,Günter Blobel,André Hoelz +6 more
TL;DR: Three crystal structures of the nucleoporin pair Seh1*Nup85 are reported, which is part of the coat cylinder, which supports the notion that the NPC coat represents another class of membrane coats.
Journal ArticleDOI
MELK is not necessary for the proliferation of basal-like breast cancer cells.
Hai-Tsang Huang,Hyuk-Soo Seo,Tinghu Zhang,Yubao Wang,Baishan Jiang,Qing Li,Dennis L. Buckley,Behnam Nabet,Justin M. Roberts,Joshiawa Paulk,Shiva Dastjerdi,Georg E. Winter,Hilary McLauchlan,Jennifer Moran,James E. Bradner,James E. Bradner,Michael J. Eck,Sirano Dhe-Paganon,Jean J. Zhao,Nathanael S. Gray +19 more
TL;DR: This study combined chemical and genetic perturbants, including the development of a novel selective maternal embryonic leucine zipper kinase (MELK) inhibitor HTH-01-091, CRISPR/Cas9-mediated MELK knockout, and a novel chemical-induced protein degradation strategy, RNA interference andCRISPR interference to validate M ELK as a therapeutic target in basal-like breast cancers.